Dashboard
Weak Long Term Fundamental Strength with a -8.90% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.32
- The company has been able to generate a Return on Equity (avg) of 1.39% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 29 Cr (Micro Cap)
47.00
32
0.00%
-0.38
1.39%
2.84
Total Returns (Price + Dividend) 
Machhar Industri for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Results Of Board Meeting Held On 23Rd May 2026 Under Regulations 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).
24-May-2026 | Source : BSEBoard of directors considered take on record and approved the Standalone and Consolidated quarterly and Yearly financial results for the quarter and year ended as on 31st March 2026 along with Independent Audit report and other agenda matter
Outcome Of Board Meeting Held On 23Rd May 2026 Under Regulations 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).
24-May-2026 | Source : BSEBoard of Directors Considered take on record and approved the Standalone and Consolidated Quarterly and Yearly Financial Results for the Quarter and Year Ended as on 31st March 2026 and Independent Audit Report along with other agenda
Board Meeting Outcome for Outcome Of Board Meeting Held On 23Rd May 2026 Under Regulations 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).
23-May-2026 | Source : BSEOutcome of the board of directors meeting for the Standalone and Consolidated quarterly and yearly results ended as on 31st March 2026 along with Audited results and Audited Report for the quarter and year ended 31st March 2026 and other matters as per agenda of the meeting.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (4.11%)
Held by 0 FIIs
Arvind Krishnagopal Machhar (15.63%)
Nagarjuna Finance Limited (3.37%)
35.18%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 8.85% vs 14.33% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -44.83% vs 1,350.00% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -14.92% vs 4.92% in Sep 2024
Growth in half year ended Sep 2025 is -6.67% vs 7.14% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -4.54% vs -0.77% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 514.29% vs -58.82% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -0.77% vs -7.38% in Mar 2025
YoY Growth in year ended Mar 2026 is 286.67% vs -74.14% in Mar 2025